Submit Deal

Submit Deal

Cover Image Silvio Frank Pupo-Casco

Silvio Frank Pupo-Casco

CEO at LOGOS CAPITAL

Investor

Deal Bio

Total Deals15

Valued Deals14

Total Value£1,916M

Avg. Deal Size£137M

Market Context

Expertise (15)

Key Relationships

Sort

Pharmaceuticals

PrivateVenture CapitalAcquisitionMinorityPrivate EquityCross Border

ANNEXON

target

ANNEXON

Adage Capital Management

bidder

Adage Capital Management

£81m

16 dealmakers

Pharmaceuticals

PrivateMinorityCross BorderAcquisitionVenture CapitalPrivate Equity

LIANBIO

target

LIANBIO

Logos Capital

bidder

Logos Capital

£239m

18 dealmakers

Private EquityAcquisitionPrivateMinorityVenture CapitalDomestic

Ikena Oncology

target

Ikena Oncology

Omega Funds

bidder

Omega Funds

£88m

15 dealmakers

Pharmaceuticals

AcquisitionCross BorderPrivate EquityPrivateMinority

Visen Pharmaceuticals

target

Visen Pharmaceuticals

Orbimed Pe

bidder

Orbimed Pe

£111m

13 dealmakers

Pharmaceuticals

MinorityPrivate EquityAcquisitionPrivateCross BorderVenture Capital

Centessa Pharmaceuticals

target

Centessa Pharmaceuticals

Janus Henderson Investors

bidder

Janus Henderson Investors

£179m

27 dealmakers

DomesticVenture CapitalPrivate EquityPrivateMinorityAcquisition

Artiva Biotherapeutics

target

Artiva Biotherapeutics

Acuta Capital

bidder

Acuta Capital

value n/a

16 dealmakers

MinorityVenture CapitalPrivate EquityPrivateAcquisitionCross Border

Omega Therapeutics

target

Omega Therapeutics

Logos Capital

bidder

Logos Capital

£91m

12 dealmakers

PrivateVenture CapitalPrivate EquityMinorityAcquisitionCross Border

Century Therapeutics

target

Century Therapeutics

Fidelity Management & Research Company

bidder

Fidelity Management & Research Company

£115m

24 dealmakers

Private EquityDe-SPACReverse TakeoverPrivateDomesticMergerAcquisitionMajority

Tango Therapeutics

target

Tango Therapeutics

Cormorant Asset Management

bidder

Cormorant Asset Management

£257m

32 dealmakers

MajorityPrivate EquityDomesticAcquisitionVenture CapitalPrivate

Boundless Bio

target

Boundless Bio

Wellington Management

bidder

Wellington Management

£75m

16 dealmakers

Pharmaceuticals

MinorityCross BorderPrivate EquityAcquisitionVenture CapitalPrivate

Gh Research

target

Gh Research

Deerfield Management Company

bidder

Deerfield Management Company

£91m

20 dealmakers

AcquisitionPrivateDomesticMinorityPrivate EquityVenture Capital

Nikang Therapeutics

target

Nikang Therapeutics

Surveyor Capital

bidder

Surveyor Capital

£141m

29 dealmakers

Cross BorderPrivateMinorityVenture CapitalAcquisitionPrivate Equity

Element Biosciences

target

Element Biosciences

Counterpoint Global - Morgan Stanley

bidder

Counterpoint Global - Morgan Stanley

£198m

12 dealmakers

AcquisitionMinorityPrivate EquityPrivateVenture CapitalCross Border

SEPTERNA

target

SEPTERNA

Ra Capital Management

bidder

Ra Capital Management

£116m

19 dealmakers

AcquisitionCross BorderMinorityPrivateVenture Capital

Third Arc Bio

target

Third Arc Bio

Vida Ventures

bidder

Vida Ventures

£127m

14 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.